Literature DB >> 24745656

Cannabis withdrawal in patients with and without opioid dependence.

Emeline Chauchard1, Oleg Goncharov, Evgeny Krupitsky, David A Gorelick.   

Abstract

BACKGROUND: Cannabis use is common among opioid-dependent individuals, but little is known about cannabis withdrawal in this population.
METHODS: Thirty inpatients (57% men) completed the Marijuana Quit Questionnaire (MJQQ) after completing acute heroin detoxification treatment in Saint Petersburg, Russia. The MJQQ collected data on motivations for quitting, withdrawal symptoms, and coping strategies used to help maintain abstinence during their most "serious" (self-defined) quit attempt made without formal treatment outside a controlled environment.
RESULTS: At the start of their quit attempt, 70% of participants smoked cannabis at least weekly (40% daily), averaging [SD] 2.73 [1.95] joints daily; 60% were heroin dependent. Subjects with heroin dependence were significantly older at the start of their quit attempt (22.9 [3.6] vs. 19.1 [2.9] years), were significantly less likely to report withdrawal irritability/anger/aggression (22% vs. 58%), restlessness (0% vs. 25%), or physical symptoms (6% vs. 33%), or to meet diagnostic criteria for DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th edition) cannabis withdrawal syndrome (6% vs. 33%), and had shorter duration of abstinence (29.6 [28.7] vs 73.7 [44.1] months) than those without heroin dependence.
CONCLUSION: Cannabis users with opioid dependence are less likely to experience cannabis withdrawal, suggesting that opiate use may prevent or mask the experience of cannabis withdrawal. RESULTS should be considered preliminary due to small convenience sample and retrospective data.

Entities:  

Keywords:  Cannabis; opioids; withdrawal

Mesh:

Year:  2014        PMID: 24745656      PMCID: PMC4127106          DOI: 10.1080/08897077.2014.898605

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  29 in total

1.  Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France.

Authors:  Gwenaëlle Vidal-Trecan; Isabelle Varescon; Norbert Nabet; Alain Boissonnas
Journal:  Drug Alcohol Depend       Date:  2003-03-01       Impact factor: 4.492

Review 2.  A review of the published literature into cannabis withdrawal symptoms in human users.

Authors:  Neil T Smith
Journal:  Addiction       Date:  2002-06       Impact factor: 6.526

3.  The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress.

Authors:  David J Allsop; Melissa M Norberg; Jan Copeland; Shanlin Fu; Alan J Budney
Journal:  Drug Alcohol Depend       Date:  2011-07-02       Impact factor: 4.492

4.  Abstinence symptoms following smoked marijuana in humans.

Authors:  M Haney; A S Ward; S D Comer; R W Foltin; M W Fischman
Journal:  Psychopharmacology (Berl)       Date:  1999-02       Impact factor: 4.530

5.  Inconsistencies in lifetime cocaine and marijuana use reports: impact on prevalence and incidence.

Authors:  M Fendrich; M E Mackesy-Amiti
Journal:  Addiction       Date:  1995-01       Impact factor: 6.526

6.  Clinical relevance of cannabis tolerance and dependence.

Authors:  R T Jones; N L Benowitz; R I Herning
Journal:  J Clin Pharmacol       Date:  1981 Aug-Sep       Impact factor: 3.126

Review 7.  Natural recovery from alcohol and drug problems: methodological review of the research with suggestions for future directions.

Authors:  L C Sobell; T P Ellingstad; M B Sobell
Journal:  Addiction       Date:  2000-05       Impact factor: 6.526

8.  An evaluation of the history of a marijuana withdrawal syndrome in a large population.

Authors:  G A Wiesbeck; M A Schuckit; J A Kalmijn; J E Tipp; K K Bucholz; T L Smith
Journal:  Addiction       Date:  1996-10       Impact factor: 6.526

9.  A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample.

Authors:  Simon J Adamson; J Douglas Sellman
Journal:  Drug Alcohol Rev       Date:  2003-09

10.  Marijuana use and treatment outcome among opioid-dependent patients.

Authors:  A J Budney; W K Bickel; L Amass
Journal:  Addiction       Date:  1998-04       Impact factor: 6.526

View more
  2 in total

Review 1.  The cannabis withdrawal syndrome: current insights.

Authors:  Udo Bonnet; Ulrich W Preuss
Journal:  Subst Abuse Rehabil       Date:  2017-04-27

Review 2.  Marijuana for Glaucoma: A Recipe for Disaster or Treatment?

Authors:  Xiaoshen Sun; Chaoying S Xu; Nisha Chadha; Allshine Chen; Ji Liu
Journal:  Yale J Biol Med       Date:  2015-09-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.